GlucoTrack Inc. has entered into a significant purchase agreement with Sixth Borough Capital Fund, LP, which has committed to acquiring up to $20 million of GlucoTrack's common stock. This agreement, dated September 11, 2025, allows GlucoTrack the option to sell shares to the investor over a 24-month period, contingent on certain conditions being met. The agreement also includes a registration rights agreement to cover the resale of shares. GlucoTrack can direct additional purchases through Add-On Purchase Notices, with specific limitations and pricing conditions outlined in the agreement. This strategic move aims to provide GlucoTrack with flexible funding options to support its operations and growth initiatives.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-013094), on September 11, 2025, and is solely responsible for the information contained therein.